Class Action Lawsuit Alerts And News Information

Fosamax Side Effects Lawsuit


Fosamax Side Effects Lawsuit

Fosamax Side Effects LawsuitAlendronic acid or Alendronate, sold as Fosamax by Merck, was licensed in 1995 as a treatment for osteoporosis. Since 1995, more than 10 million patients have taken the drug. The bisphosphonate drug is mostly sold as a treatment for bone diseases, where there is a loss of bone mass. Fosamax is designed for the treatment of bone loss due to advanced cancer, Paget’s disease, or post-menopausal osteoporosis.

FDA Warning on Fosamax

In 2004, the Food and Drug Administration asked Merck & Co. to issue a warning about the Fosamax side effects; however, a number of patients allege the drug manufacturer never informed them that the bisphosphonate drug posed a risk of jaw necrosis. About 3,000 cases of jaw necrosis have been reported among bisphosphonate drug users, including Fosamax, since 2003. In 2010, the FDA issued another warning for Fosamax consumers that they were at the risk of thigh fracture following long-term use of the drug.

Fosamax Lawsuit

Merck faces more than 900 Lawsuit nationwide over the side effects of Fosamax. In a recent lawsuit, in 2010, a federal district judge in Manhattan refused to dismiss a Fosamax lawsuit against defendant Merck & Co Inc's. The plaintiff from Indiana, Louise Maley, had alleged that after having taken Fosamax for eight-long years, she suffered jaw damage.

Fosamax Side Effects

Though Fosamax effectively works to prevent bone loss, serious side effects have been reported as a result of the use of the drug.

Read more: Fosamax Side Effects Lawsuit

Ortho Evra Lawsuit


Ortho Evra Side Effects Lawsuit

Ortho Evra contraceptive skin patch by Johnson & Johnson’s subsidiary Ortho-McNeil has been popular since November 2001. The patch contains a combination of hormones that prevents ovulation in females. It also causes changes in cervical mucus, which, in turn, prevents sperms from reaching the uterus. However, Ortho Evra has serious side effects. According to an Associated Press investigation report, the hormonal contraception patch triples the risk of developing life-threatening blood clots. The serious side effects of the drug include deep vein thrombosis, strokes, pulmonary embolisms, heart attacks, and deaths.

Ortho Evra Complaints and Warnings

According to a study conducted by the FDA in 2004, Ortho Evra led to a three-fold increase in blood clot-related fatal incidents, such as pulmonary embolisms, strokes, heart attacks, and deaths. The reports, made public by the Associated Press in July 2005, claimed that there were at least 23 Ortho Evra deaths, including 17 caused by blood clots until 2004. The study was also apprehensive that the actual side effects were more widespread as the post-marketing reviews covered only 1-10 percent patch users.

The first known Ortho Evra fatality was reported in April 2004. Autopsy of an 18-year-old Manhattan fashion student revealed a blood clot in the lung. The victim was using Ortho Evra and the medical examiner blamed the side effects of the birth control patch for the young woman's death. Another woman, a 25 year-old-mother of three, died of blood clots in her brain. The medical reports held hormones released by Ortho Evra responsible for the death.

In November 2005, the FDA ordered the manufacturer to modify labels on the drug reflecting the increased risk of blood clots and other severe side effects. An advisory issued by Ortho McNeil within days warned that the patch exposed users to 60% more estrogen than pills, which could lead to serious health risks.  In March 2006, the FDA announced further review of Ortho Evra and asked label update on the package following a comparative study on the side effects of the patch and other birth control pills. According to the research, the excessive hormones in the patch do not dilute during the digestive process, unlike other pills. They are absorbed directly into the blood stream and cause higher concentration of estrogen, which puts users at a greater risk of clots, thrombosis, and heart strokes.

The consumer advocacy group Public Citizen filed a petition signed by 80,000 individuals to FDA demanding recall of Ortho Evra in May 2008. The petition mentioned cases of unreasonable blood clot and other serious health problems that the birth control patch caused within six months of taking it.

Ortho Evra Side Effects

Blood Clots:

Thromboembolic risks are the most documented side effect of Ortho Evra. The patch increases level of estrogen and progestin hormones in the blood. It releases 60 percent more estrogen compared to birth control pills, and this directly enters the patient’s blood stream, putting them at a greater risk of developing blood clots. Most of the Ortho Evra side effect victims are diagnosed with deep vein thrombosis and pulmonary embolism. Blood clots mostly develop in a deep vein in the pelvic region or legs. It breaks off and travels upward to the lungs, which can cause major artery blocks.

Read more: Ortho Evra Lawsuit

Bextra Lawsuit Attorney


Bextra Lawsuit Attorney

Bextra Side Effects LawsuitPfizer withdrew Bextra from the U.S. market in April 2005 on the recommendation of the FDA. Introduced in November 2001, this non-steroidal anti-inflammatory drug was used to treat pain, stiffness, and inflammation associated with arthritis and other ailments. However, a number of research reports and government reviews held the drug responsible for causing rare skin reactions and increased risk of fatal cardiovascular problems in users.

Bextra Complaints

Bextra was the second Cox-2 inhibitor to be withdrawn from the market after the Vioxx recall in 2004. Some of the side effects of the drug includes increased risk of heart attack, stroke, rare skin disease called Stevens–Johnson syndrome.

In October 2004, Pfizer acknowledged the cardiovascular side effects of Bextra. A report presented to the American Heart Association also highlighted that patients using Bextra were 2.19 fold more likely to suffer heart attack or stroke. A study published by the University of Pennsylvania in November claimed that Bextra posed greater risk of heart attack and stroke than Vioxx, which was withdrawn a month before the report had been made public.

In December 2004, the FDA issued a public health advisory asking doctors to limit use of Bextra and diagnose heart patients properly before prescribing the drug. Four months later, the federal regulator ordered Pfizer to immediately stop selling Bextra, citing major heart and skin problems caused by the drug. The European Union and Canada also suspended the sale of the drug with immediate effect. In December 2005, Health Canada banned Bextra on the recommendations of an expert panel.

In March 2009, a former sales manager from Boston pleaded guilty to selling Bextra inappropriately. She had directed 100 sales representatives working under her supervision to promote the drug for reasons rejected by the FDA. About half a dozen whistleblowers followed the suit and disclosed the unlawful practices adopted by Pfizer for marketing Bextra to the federal investigators.

Bextra Side Effects

Skin Disorders

The FDA has received reports of 87 cases of severe skin reactions, including four deaths, linked to Bextra. Stevens-Johnson Syndrome, a toxic epidermal necrolysis disorder, is the most prominent side effect of the drug. Many patients found themselves affected with the syndrome within two weeks of taking the drug. This complex syndrome affects the skin and mucous membranes, leading to rashes, mucosal lesions, and cell death.

Cardiovascular Side Effects

Read more: Bextra Lawsuit Attorney


Botox Side Effects Lawsuit Attorney

The New Jersey Assembly Health and Senior Services Committee approved a bill on May 19th proposing a ban on injecting Botox to people younger than 18. The bill prohibits minors from taking botulinum toxin injections for cosmetic purposes unless a doctor prescribes them for medical problems. It cites a report by the American Society for Aesthetic Plastic Surgery that warns of large-scale use of these injections by teenagers and concomitant side effects. It followed the widely published news of a California mother giving Botox injections to her 8-year-old daughter to prepare her for a beauty pageant contest. The San Francisco Human Services Agency began an investigation and the mother was relieved of the responsibility of the custody of the child after the incident sparked protests from the medical community and child right activists.

Botox is used to treat strabismus, facial spasms, and neurological disorders by preventing abnormal muscle contractions. Its cosmetic use has been very popular as the botulinum toxin protein smoothes facial wrinkles. However, if not carefully targeted, the drug can lead to serious side effects, including death.

Botox Side Effects Complaints

The FDA allowed Allergan to manufacture and distribute Botox in 1989 for therapeutic use in patients above 12 years. It approved its cosmetic use in April 2002. However, the drug was linked to deaths and several other harmful side effects soon. A report in the Journal of American Academy of Dermatology’s September 2005 issue revealed that about 28 individuals had died due to Botox between 1989 and 2003. This led to demand for investigations, which revealed that Botox could spread to other areas in the body and impact them. The FDA admitted in February 2008 that the drug was responsible for serious adverse reactions, such as respiratory failure and death.

In April 2009, the FDA announced updated

Read more: Botox Side Effects Lawsuit Attorney

Facebook Lawsuit

Facebook Privacy Lawsuit

A U.S. District Court in San Jose, California, has allowed a lawsuit accusing Facebook of privacy violations to proceed. The lawsuit has claimed that the most popular social-networking site in the world gave advertisers unauthorized access to personal information of users when they clicked on ads. Though the court dismissed eight claims due to lack of tangible evidence, it rejected the plea by the social-networking site to dismiss the entire lawsuit and allowed five claims to be refiled. Judge James Ware observed that the allegations by the plaintiffs were enough to establish the fact that they have suffered the injury.

The plaintiffs, two individuals from California, filed the lawsuit against Facebook earlier this year seeking damages for injury caused on eight grounds, violation of the Electronic Communications Privacy Act, Stored Communications Act, fraud, breach of contract, unfair competition, and other claims. According to the plaintiffs, Facebook allowed advertisers to access their profiles and personal information after they clicked on advertisements between February 2010 and March 2010. They claim this act of the social-networking major make them feel “injured,” as advertisers are not authorized to access names, genders, and pictures of users without their consent.

Similar Privacy Lawsuits Against Facebook

Facebook is the largest social-networking site with more than 500 million members. However, there have been several complaints against the site for failure to protect the privacy of users. Facebook is also listed by the European Union for possible privacy-rule breaches and unauthorized use of personal data. In 2005, two MIT students demonstrated the possibility of data mining on the Facebook by downloading over 70,000 profile information.

Facebook Data Mining Case in Canada

In May 2009, the Privacy Commission of Canada suggested Internet providers to block Facebook, as it did not comply with national privacy laws. It preceded the famous "minefield of privacy invasion" suit filed by three Ottawa University law students. Facebook agreed to comply with privacy norms suggested under the Canadian Personal Information Protection and Electronic Documents Act after persistent legal pressure.

California Class Action Lawsuits Against Facebook

Read more: Facebook Class Action Lawsuit